Literature DB >> 9675028

Purification and characterization of recombinant human neutrophil leukotriene B4 omega-hydroxylase (cytochrome P450 4F3).

Y Kikuta1, E Kusunose, H Sumimoto, Y Mizukami, K Takeshige, T Sakaki, Y Yabusaki, M Kusunose.   

Abstract

Recombinant human neutrophil leukotriene B4 (LTB4) omega-hydroxylase (cytochrome P450 4F3) has been purified to a specific content of 14. 8 nmol of P450/mg of protein from yeast cells. The purified enzyme was homogenous as judged from the SDS-PAGE, with an apparent molecular weight of 55 kDa. The enzyme catalyzed the omega-hydroxylation of LTB4 with a Km of 0.64 microM and Vmax of 34 nmol/min/nmol of P450 in the presence of rabbit hepatic NADPH-P450 reductase and cytochrome b5. Furthermore, various eicosanoids such as 20-hydroxy-LTB4, 6-trans-LTB4, lipoxin A4, lipoxin B4, 5-HETE and 12-HETE, and 12-hydroxy-stearate and 12-hydroxy-oleate were efficiently omega-hydroxylated, although their Km values were much higher than that of LTB4. In contrast, no activity was detected toward laurate, palmitate, arachidonate, 15-HETE, prostaglandin A1, and prostaglandin E1, all of which are excellent substrates for the CYP4A fatty acid omega-hydroxylases. This is the first time human neutrophil LTB4 omega-hydroxylase has been isolated in a highly purified state and characterized especially with respect to its substrate specificity. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675028     DOI: 10.1006/abbi.1998.0724

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

Review 1.  Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.

Authors:  Amanda L Johnson; Katheryne Z Edson; Rheem A Totah; Allan E Rettie
Journal:  Adv Pharmacol       Date:  2015-06-27

2.  Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes.

Authors:  Auinash Kalsotra; Sayeepriyadarshini Anakk; Chad L Brommer; Yasushi Kikuta; Edward T Morgan; Henry W Strobel
Journal:  Arch Biochem Biophys       Date:  2007-03-15       Impact factor: 4.013

3.  Microsomal reductase activity in patients with thyroid neoplasms.

Authors:  Elena V Proskurnina; Maria V Fedorova; Madina M Sozarukova; Aleksandr E Mitichkin; Igor V Panteleev; Evgeny V Svetlov
Journal:  Endocrine       Date:  2020-10-03       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.